AI assistant
Sending…
BeOne Medicines Ltd. — Director's Dealing 2024
Mar 13, 2024
30073_dirs_2024-03-13_56d58517-2047-41f6-a8ef-be1e04f0bc89.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2024-03-11
Reporting Person: Glazer Donald W. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-11 | Ordinary Shares | G | 82020 | — | Disposed | 2702123 | Direct |
Footnotes
F1: Bona fide gifts of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
More from BeOne Medicines Ltd.
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 14
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Director's Dealing
2026
Feb 6